Competitors
| Companies | Market Cap | G | R | O | W | T | H |
|---|---|---|---|---|---|---|---|
|
Eli Lilly and NYSE:LLY |
854,72 B | 23,56% | 6/6 | 34,75% | 15,02% | 31,91% | UP |
|
Johnson & Johnson NYSE:JNJ |
581,22 B | 5,27% | 5/5 | 6,91% | -30,36% | 2,36% | UP |
|
Merck NYSE:MRK |
303,01 B | 7,67% | 6/6 | -21,36% | -12,17% | 8,41% | UP |
|
Pfizer NYSE:PFE |
153,13 B | 7,82% | 4/6 | -5,31% | 22,08% | 0,30% | UP |
|
Bristol-Myers Squibb NYSE:BMY |
121,42 B | 1,77% | 5/6 | -0,30% | -0,79% | 7,62% | UP |
|
Vertex Pharmaceuticals NasdaqGS:VRTX |
113,63 B | 13,44% | 6/6 | 6,43% | -0,97% | 24,90% | DOWN |
|
Regeneron Pharmaceuticals NasdaqGS:REGN |
78,80 B | 9,26% | 5/6 | 5,41% | 4,79% | 14,28% | UP |
|
Zoetis NYSE:ZTS |
50,46 B | 9,80% | 6/6 | 7,18% | 47,26% | 20,84% | DOWN |
|
United Therapeutics NasdaqGS:UTHR |
25,19 B | 15,13% | 5/6 | 2,41% | -47,23% | 13,96% | UP |
|
Viatris NasdaqGS:VTRS |
15,85 B | -3,69% | 4/6 | 2,85% | -36,56% | 24,91% | UP |
|
Madrigal Pharmaceuticals NasdaqGS:MDGL |
12,03 B | 0,00% | 2/4 | 0,00% | 0,00% | 22,45% | UP |
|
Catalent NYSE:CTLT |
11,52 B | -5,82% | 2/6 | 27,69% | -22,42% | 0,03% | UP |
|
Cytokinetics NasdaqGS:CYTK |
7,96 B | -1,08% | 1/6 | 4,92% | -41,85% | 42,44% | UP |
|
Balchem NasdaqGS:BCPC |
5,61 B | 8,75% | 6/6 | 8,46% | 0,16% | 15,67% | UP |
|
Indivior Pharmaceuticals NasdaqGS:INDV |
3,94 B | 28,91% | 5/6 | 13,62% | -5,70% | 10,68% | UP |
|
TG Therapeutics NasdaqCM:TGTX |
4,98 B | 63,45% | 3/5 | 33,54% | 93,06% | 36,38% | UP |
|
Corcept Therapeutics NasdaqCM:CORT |
4,49 B | 10,36% | 5/6 | 118,76% | 17,72% | 42,01% | DOWN |
|
Ligand Pharmaceuticals NasdaqGM:LGND |
4,09 B | 7,83% | 5/6 | 3,60% | -51,31% | 17,85% | UP |
|
Supernus Pharmaceuticals NasdaqGM:SUPN |
2,97 B | 2,48% | 3/6 | 8,61% | -29,54% | 26,21% | UP |
|
Soleno Therapeutics NasdaqCM:SLNO |
2,72 B | 0,00% | 3/4 | 0,00% | 0,00% | 0,93% | UP |
